Awards to address antivirals
Federal Telemedicine News, June 6, 2022
The National Institute of Allergy and Infectious Diseases has awarded about $577 million to establish nine Antiviral Drug Discovery Centers for Pathogens of Pandemic concern. Awards include funding to help the University of Texas Medical Branch and Novartis work together to discover drugs to fight off the next pandemic. The partnership received $56 million from NIAID, referred to as the UTMB Novartis Alliance for Pandemic Preparedness. The partnership will focus on three major classes of viruses with pandemic potential. It will look at validated drug targets as well as phenotypic screening. This will make it possible to discover clinical drug candidates as well as new targets that will advance the fundamental understanding of the biology of viruses.